SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    J. Luo, B. Ko, M. Elliott, M. Zhou, D. A. Lindhout, V. Phung, C. To, R. M. Learned, H. Tian, A. M. DePaoli, L. Ling, A nontumorigenic variant of FGF19 treats cholestatic liver diseases, Science Translational Medicine, 2014, 6, 247, 247ra100

    CrossRef

  2. 2
    Ryosuke Tateishi, Takeshi Okanoue, Naoto Fujiwara, Kiwamu Okita, Kendo Kiyosawa, Masao Omata, Hiromitsu Kumada, Norio Hayashi, Kazuhiko Koike, Clinical characteristics, treatment, and prognosis of non-B, non-C hepatocellular carcinoma: a large retrospective multicenter cohort study, Journal of Gastroenterology, 2014,

    CrossRef

  3. 3
    Annarosa Floreani, Alice Spinazzè, Llorenc Caballeria, Ana Reig, Nora Cazzagon, Irene Franceschet, Alessandra Buja, Patrizia Furlan, Kenichi Harada, Patrick SC Leung, M. Eric Gershwin, Albert Pares, Extrahepatic Malignancies in Primary Biliary Cirrhosis: A Comparative Study at Two European Centers, Clinical Reviews in Allergy & Immunology, 2014,

    CrossRef

  4. 4
    Kirsten Boonstra, Robin Bokelaar, Paul H. Stadhouders, Hans A. Tuynman, Alexander C. Poen, Karin M. van Nieuwkerk, Ellen M. Witteman, Dörte Hamann, Ben J. Witteman, Ulrich Beuers, Cyriel Y. Ponsioen, Increased cancer risk in a large population-based cohort of patients with primary biliary cirrhosis: follow-up for up to 36 years, Hepatology International, 2014,

    CrossRef

  5. 5
    Felipe A. Castro, Xiangdong Liu, Asta Försti, Jianguang Ji, Jan Sundquist, Kristina Sundquist, Jill Koshiol, Kari Hemminki, Increased Risk of Hepatobiliary Cancers After Hospitalization for Autoimmune Disease, Clinical Gastroenterology and Hepatology, 2014, 12, 6, 1038

    CrossRef

  6. You have free access to this content6
    Kenichi Harada, Yasuni Nakanuma, Prevalence and risk factors of hepatocellular carcinoma in Japanese patients with primary biliary cirrhosis, Hepatology Research, 2014, 44, 2
  7. 7
    Y. Liang, Z. Yang, B. Qin, R. Zhong, Primary Sjogren's syndrome and malignancy risk: a systematic review and meta-analysis, Annals of the Rheumatic Diseases, 2014, 73, 6, 1151

    CrossRef

  8. 8
    J. Ouyang, X. Gou, Y. Ma, Q. Huang, T. Jiang, Prognostic value of 1p deletion for multiple myeloma: a meta-analysis, International Journal of Laboratory Hematology, 2014, 36, 5
  9. 9
    V. Tang, J.R. Friedman, Pathobiology of Human Disease, 2014,

    CrossRef

  10. 10
    Weirong Ren, Xingshun Qi, Zhiping Yang, Guohong Han, Daiming Fan, Prevalence and risk factors of hepatocellular carcinoma in Budd–Chiari syndrome, European Journal of Gastroenterology & Hepatology, 2013, 25, 7, 830

    CrossRef

  11. 11
    Zaixing Yang, Yan Liang, Renqian Zhong, Reply to Risk factors associated with hepatocellular carcinoma in primary biliary cirrhosis, Hepatology, 2013, 58, 4
  12. 12
    Annarosa Floreani, Fabio Farinati, Risk factors associated with hepatocellular carcinoma in primary biliary cirrhosis, Hepatology, 2013, 58, 4